Cd16a binding proteins and use for the treatment of immune...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2487932

CD16A binding proteins useful for the reduction of a deleterious immune response are described. In one aspect, humanized anti-CD16A antibodies, optionally lacking effector function, are used for treatment of immune disorders such as idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia.

L'invention concerne des protéines de liaison à CD16A, utiles pour diminuer une réponse immunitaire délétère. Dans un aspect, des anticorps anti-CD16A, éventuellement dépourvus de fonction effectrice, sont utilisés pour le traitement de troubles immunitaires, tels que le purpura thrombocytopénique idiopathique ou l'anémie hémolytique autoimmune.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cd16a binding proteins and use for the treatment of immune... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cd16a binding proteins and use for the treatment of immune..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cd16a binding proteins and use for the treatment of immune... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1520009

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.